News

Video

Envision Summit 2025: How to use the new G2211 code

At the Envision Summit 2025 in San Juan, Puerto Rico, Lana Rifkin, MD, gave clinicians advice on how, and when it may be most appropriate to use the new G2211 code.

At the Envision Summit 2025 in San Juan, Puerto Rico, Lana Rifkin, MD, gave clinicians advice on how, and when it may be most appropriate to use the new G2211 code.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

Lana Rifkin, MD:

My name is Lana Rifkin, and I am a uveitis specialist in Boston, Massachusetts. I'm the director of the uveitis service at Ophthalmic Consultants of Boston. My session this year was, it's Friday afternoon–what uveitis walks in. I had a fabulous panel with really excellent speakers. We focused on how to evaluate and manage typical cases of uveitis that may walk into your clinic at any given moment.

My talk was actually not clinical, but on billing. My talk was the new G2211 billing code, how to use it appropriately. Because I think that in addition to the great clinical care that we provide, it's very important for us as ophthalmologists, and especially us as women, to know how to bill appropriately for the work that we do. The G2211 code is a new code that was introduced about a year ago. It's a complex code designed to encompass and reimburse for the very complex care that we provide for our patients in longitudinal format. So this applies to patients that are ongoing, that they're with us for the long haul. That we serve as the focal point of their care. Especially in uveitis, we see a lot of patients who have other complicated, systemic diseases, but we're the focal point as the eye disease drives their care. So this code recognizes the time and the mental capacity that it takes to organize all that, to communicate to the patient, with their families, with their other caregivers and other physicians. All of that takes time and effort, and this code recognizes that and reimburses a little bit for our time.

So the advice that I would have is don't be afraid of it. This code is not just designed for primary care physicians, but it is designed for those of us who do provide longitudinal care. Again, with the complexity of the disease processes and the patients that we see, it's very important to know how to bill it, when to bill it, when it's appropriate. So the main advice I have is don't be afraid. Learn the parameters. You can use it with any E&M code. It cannot be used with eye codes, but with any E&M code, even level fours and level fives. Even if you're billing a higher E&M code, it doesn't mean that you cannot bill this additional complex code.

Also extremely important is documentation. If you didn't document it, it didn't happen. But if you know that you are providing longitudinal care, that you are communicating with the patient, explaining the vision threatening nature of their disease. If you're communicating with other physicians and you document it, then it is absolutely appropriate to be billing the G2211 complex code.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.